FIELD: medicine.
SUBSTANCE: method involves carrying out intracerebral implantation of spinal marrow stem cells during neurosurgical intervention in the injured area. Transplantation is carried out in early and late recovery period after stroke. The whole autologic mononuclear cells complex is introduced as the stem cells separated from spinal marrow aspirate without selecting individual cell fractions and their culturing.
EFFECT: simplified treatment course; reduced neurological deficiency.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING VERTEBRAL COLUMN INJURY CASES | 2005 |
|
RU2286160C1 |
| METHOD OF OBTAINING CONDITIONED MEDIA WITH REGENERATIVE POTENTIAL FOR INTRANASAL INTRODUCTION IN TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2016 |
|
RU2637407C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING ISCHEMIC INSULT | 2004 |
|
RU2258521C1 |
| BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
| METHOD FOR TREATING THE CASES OF CHRONIC DIFFUSE HEPATIC DISEASES | 2004 |
|
RU2283113C2 |
| METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE, OR MYOCARDIAL INFARCTION AND ITS AFTEREFFECTS, OR CEREBRAL ISCHEMIA INDUCED BY ATHEROSCLEROSIS OR ACUTE DYSFUNCTION OF CEREBRAL CIRCULATION, AND ITS AFTEREFFECTS, OR ATHEROSCLEROSIS-INDUCED ISCHEMIA OF INFERIOR LIMBS | 2005 |
|
RU2284190C1 |
| AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
| METHOD OF TREATING MENTAL AND NEURAL DISORDERS | 2009 |
|
RU2413524C1 |
